These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 35028297)

  • 21. Comparison of self-report and clinician-rated schizotypal traits in schizotypal personality disorder and community controls.
    Chan CC; Bulbena-Cabre A; Rutter S; Benavides C; McClure MM; Calabrese W; Rosell DR; Koenigsberg HW; Goodman M; New AS; Hazlett EA; Mercedes Perez-Rodriguez M
    Schizophr Res; 2019 Jul; 209():263-268. PubMed ID: 30635257
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Aberrant Salience Inventory: a new measure of psychosis proneness.
    Cicero DC; Kerns JG; McCarthy DM
    Psychol Assess; 2010 Sep; 22(3):688-701. PubMed ID: 20822281
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cannabis use and schizotypy: the role of social anxiety and other negative affective states.
    Najolia GM; Buckner JD; Cohen AS
    Psychiatry Res; 2012 Dec; 200(2-3):660-8. PubMed ID: 22920791
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Do schizotypy features predict cannabis problems in partnered community adults?
    Brown WC; Leonard K; Stasiewicz PR; Testa M
    Addict Behav; 2021 May; 116():106819. PubMed ID: 33465724
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The association of striatal volume and positive schizotypy in healthy subjects: intelligence as a moderating factor.
    Meller T; Ettinger U; Grant P; Nenadić I
    Psychol Med; 2020 Oct; 50(14):2355-2363. PubMed ID: 31530329
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Aberrant salience in cannabis-induced psychosis: a comparative study.
    Ricci V; Di Muzio I; Ceci F; Di Carlo F; Mancusi G; Piro T; Paggi A; Pettorruso M; Vellante F; De Berardis D; Martinotti G; Maina G
    Front Psychiatry; 2023; 14():1343884. PubMed ID: 38260781
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assessing the construct validity of aberrant salience.
    Schmidt K; Roiser JP
    Front Behav Neurosci; 2009; 3():58. PubMed ID: 20057930
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Schizotypy and psychosis-like experiences from recreational cannabis in a non-clinical sample.
    Barkus E; Lewis S
    Psychol Med; 2008 Sep; 38(9):1267-76. PubMed ID: 18205966
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Validation study of the French schizotypal personality questionnaire in a sample of adolescents: a confirmatory factor analysis].
    Badoud D; Chanal J; Van der Linden M; Eliez S; Debbané M
    Encephale; 2011 Sep; 37(4):299-307. PubMed ID: 21981891
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Psychometric properties of the Brief Version of the Schizotypal Personality Questionnaire in relatives of patients with schizophrenia-spectrum disorders and non-psychiatric controls.
    Compton MT; Chien VH; Bollini AM
    Schizophr Res; 2007 Mar; 91(1-3):122-31. PubMed ID: 17258893
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cannabis-induced psychotic-like experiences are predicted by high schizotypy. Confirmation of preliminary results in a large cohort.
    Stirling J; Barkus EJ; Nabosi L; Irshad S; Roemer G; Schreudergoidheijt B; Lewis S
    Psychopathology; 2008; 41(6):371-8. PubMed ID: 18787359
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Convergent validity of the Chinese version of the Multidimensional Schizotypy Scale.
    Wang Y; Hu HX; Wang LL; Zhang YJ; Yang HX; Zhou HY; Li X; Lui SSY; Chan RCK
    Asian J Psychiatr; 2021 Jul; 61():102671. PubMed ID: 33984618
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Schizotypy but not Cannabis Use Modestly Predicts Psychotogenic Experiences: A Cross-Sectional Study Using the Oxford-Liverpool Inventory of Feelings and Experiences (O-LIFE).
    Airey ND; Hammersley R; Reid M
    J Addict; 2020; 2020():5961275. PubMed ID: 33123406
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterizing psychosis-relevant phenomena and cognitive function in a unique population with isolated, chronic and very heavy cannabis exposure.
    D'Souza DC; Ganesh S; Cortes-Briones J; Campbell MH; Emmanuel MK
    Psychol Med; 2020 Oct; 50(14):2452-2459. PubMed ID: 31615592
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aberrant salience in adolescents is related to indicators of psychopathology that are relevant in the prodromal phases of psychosis.
    Lisi G; Raballo A; Ribolsi M; Niolu C; Siracusano A; Preti A
    Early Interv Psychiatry; 2021 Aug; 15(4):856-864. PubMed ID: 32893966
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Associations between past alcohol, cannabis, and cocaine use and current schizotypy among first-degree relatives of patients with schizophrenia and non-psychiatric controls.
    Compton MT; Chien VH; Bollini AM
    Psychiatr Q; 2009 Sep; 80(3):143-54. PubMed ID: 19396546
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cognitive fusion and affective isolation: Blurred self-concept and empathy deficits in schizotypy.
    Kállai J; Rózsa S; Hupuczi E; Hargitai R; Birkás B; Hartung I; Martin L; Herold R; Simon M
    Psychiatry Res; 2019 Jan; 271():178-186. PubMed ID: 30481696
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Polydrug use, cannabis, and psychosis-like symptoms.
    Van Dam NT; Earleywine M; DiGiacomo G
    Hum Psychopharmacol; 2008 Aug; 23(6):475-85. PubMed ID: 18449850
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hemispheric language asymmetry in first episode psychosis and schizotypy: the role of cannabis consumption and cognitive disorganization.
    Herzig DA; Sullivan S; Lewis G; Corcoran R; Drake R; Evans J; Nutt D; Mohr C
    Schizophr Bull; 2015 Mar; 41 Suppl 2(Suppl 2):S455-64. PubMed ID: 25543118
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of aberrant salience in the association between cannabis use frequency and psychotic experiences among racial and ethnic minoritized youth.
    Anglin DM; Tikhonov AA; Tayler R; DeVylder J
    Schizophr Res; 2021 Dec; 238():36-43. PubMed ID: 34583102
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.